CYTK — CYTOKINETICS INC

Ownership history in INCEPTIONR LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which INCEPTIONR LLC reported a position in CYTOKINETICS INC (CYTK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2023 Q4)
Avg. % of fund
0.12%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,719 -5,714 -60.6% 0.05% $204K $54.96
2025 Q1 ADDED 9,433 +4,187 +79.8% 0.11% $379K $40.19
2024 Q1 ADDED 5,246 +1,782 +51.4% 0.09% $368K $70.11
2023 Q4 INITIATED 3,464 — — 0.21% $289K —
% of Fund (quarterly)    CYTK price (monthly, adj. close)

Other funds also holding CYTK

As of 2025 Q4 — sorted by position size

Foresite Capital Management IV, LLC 3Y 7Y 12.68% Sarissa Capital Management LP 3Y 7Y 11.3% DAFNA Capital Management LLC 3Y 7Y 5.48% Integral Health Asset Management, LLC 3Y 4.42% Rosalind Advisors, Inc. 4.36% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.22% Melqart Asset Management (UK) Ltd 3Y 7Y 3.9% Exome Asset Management LLC 3.79% Deep Track Capital, LP 3Y 3.78% Checkpoint Capital L.P. 3.31%
← Back to INCEPTIONR LLC Holdings